Myriad Genetics, Inc. (MYGN) P/E ratio
The P/E ratio of Myriad Genetics, Inc. (MYGN) was 463.0× at the end of fiscal 2019 (June 30, 2019). That is 2192.1% higher than the 20.2× of fiscal 2018. Figures as of 18 Nov 2026, 11:35 UTC, from the company's filings with the SEC and Yahoo Finance.
Key facts
- P/E ratio, fiscal 2019
- 463.0×
- Change on fiscal 2018
- +2192.1%
- Highest on record
- 463.0×fiscal 2019
- Lowest on record
- 9.7×fiscal 2010
- Fiscal years on record
- 112009–2019
Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Figures, not advice.
Myriad Genetics, Inc. P/E ratio, in more detail
Across the 11 fiscal year-ends on record (2009–2019), the highest was 463.0× in fiscal 2019 and the lowest 9.7× in fiscal 2010.
P/E ratio at each fiscal year-end
Myriad Genetics, Inc. P/E ratio, year by year
| Fiscal year | P/E ratio | Change | Year ended | Share price at year-end | Diluted EPS |
|---|---|---|---|---|---|
| 2025 | — | — | $6.15 | -$3.95 | |
| 2024 | — | — | $13.71 | -$1.41 | |
| 2023 | — | — | $19.14 | -$3.18 | |
| 2022 | — | — | $14.51 | -$1.39 | |
| 2021 | — | — | $27.60 | -$0.35 | |
| 2020 | — | — | $19.77 | -$2.99 | |
| 2020 | — | — | $11.34 | -$2.69 | |
| 2019 | 463.0× | 2,192.1% up | $27.78 | $0.06 | |
| 2018 | 20.2× | 80.5% down | $37.37 | $1.85 | |
| 2017 | 103.4× | 440.4% up | $25.84 | $0.25 | |
| 2016 | 19.1× | 39.8% down | $30.60 | $1.60 | |
| 2015 | 31.8× | 83.6% up | $33.99 | $1.07 | |
| 2014 | 17.3× | 13.9% up | $38.92 | $2.25 | |
| 2013 | 15.2× | 17.0% down | $26.87 | $1.77 | |
| 2012 | 18.3× | 11.4% down | $23.77 | $1.30 | |
| 2011 | 20.6× | 112.7% up | $22.71 | $1.10 | |
| 2010 | 9.7× | 76.6% down | $14.95 | $1.54 | |
| 2009 | 41.5× | — | $35.65 | $0.86 |
Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.
How it is calculated
The P/E ratio is the share price divided by earnings per share: for past years this page divides the closing price for the month each fiscal year ended in by that year's diluted earnings per share, and a year with a loss has no P/E.
How to read it
It is the number of years of current profit the price pays for — a high figure means investors expect growth, and it is best judged against the company's own history.
Myriad Genetics, Inc., figure by figure
- Myriad Genetics, Inc. market cap
- Myriad Genetics, Inc. revenue
- Myriad Genetics, Inc. earnings
- Myriad Genetics, Inc. earnings per share (EPS)
- Myriad Genetics, Inc. P/S ratio
- Myriad Genetics, Inc. P/B ratio
- Myriad Genetics, Inc. free cash flow
- Myriad Genetics, Inc. operating margin
- Myriad Genetics, Inc. dividend
- Myriad Genetics, Inc. shares outstanding
- Myriad Genetics, Inc. total debt
- Myriad Genetics, Inc. cash on hand
- Myriad Genetics, Inc. total assets
- Myriad Genetics, Inc. return on equity (ROE)
- Myriad Genetics, Inc. return on invested capital (ROIC)
Myriad Genetics, Inc. (MYGN) overview: price, valuation and scorecard
Myriad Genetics, Inc. P/E ratio: questions and answers
What is Myriad Genetics, Inc.'s P/E ratio?
The P/E ratio of Myriad Genetics, Inc. (MYGN) was 463.0× at the end of fiscal 2019 (June 30, 2019). That is 2192.1% higher than the 20.2× of fiscal 2018.
What are the highest and lowest P/E ratio figures on record for Myriad Genetics, Inc.?
Across the 11 fiscal year-ends on record (2009–2019), the highest was 463.0× in fiscal 2019 and the lowest 9.7× in fiscal 2010.
How is Myriad Genetics, Inc.'s P/E ratio calculated?
The P/E ratio is the share price divided by earnings per share: for past years this page divides the closing price for the month each fiscal year ended in by that year's diluted earnings per share, and a year with a loss has no P/E. For Myriad Genetics, Inc. it is on record here for 11 fiscal years, 2009 to 2019.
Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.
Learn: P/E ratio
All stocks guides →- P/E ratio explained: what a high or low figure means
The price-to-earnings (P/E) ratio is a share's price divided by its earnings per share. A stock at $100 earning $5 a share has a P/E of 20: buyers pay $20 for each dollar of yearly profit. A high P/E usually means the market expects profit to grow; a low one can mean doubt, not a bargain.
- PEG ratio: P/E adjusted for growth, and its limits
The PEG ratio is a stock's P/E divided by its expected yearly earnings growth in percent. A P/E of 20 with 10% expected growth gives a PEG of 2; with 20% growth, a PEG of 1. A PEG near 1 is the traditional rough mark of a fair price, but the growth figure is a forecast and often wrong.
- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
Cite this page
Funkfolio, “Myriad Genetics, Inc. (MYGN) P/E ratio”, data as of 18 November 2026. https://funkfolio.com/stock/MYGN/pe-ratio
Underlying data: the company's filings with the SEC and Yahoo Finance.